Evidence map›Paper›PMID 30918121›Full record

Trial reportSexually transmitted infections2019

Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial.

Ellen White, David T Dunn, Monica Desai, Mitzy Gafos, Peter Kirwan, Ann K Sullivan, Amanda Clarke, Sheena McCormack, PROUD study group

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Sexually transmitted infections, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Circumcision for HIV Prevention in Men Who Have Sex With Men: An Updated Meta-Analysis.Journal of acquired immune deficiency syndromes (1999) · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Optimizing Screening for HIV.Open forum infectious diseases · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Ellen WhiteMedical Research Council Clinical Trials Unit at University College London, London, UK ellen.white@ucl.ac.uk.
David T DunnMedical Research Council Clinical Trials Unit at University College London, London, UK.
Monica DesaiNational Institute for Health and Care Excellence, Manchester, UK.
Mitzy GafosDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
Peter KirwanHIV and STI Department, National Infection Service, Public Health England, London, UK.
Ann K SullivanSt Stephen's Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Amanda ClarkeDepartment of HIV, Sexual Health and Contraception, Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Sheena McCormackMedical Research Council Clinical Trials Unit at University College London, London, UK.
PROUD study group
University College London · GBChelsea and Westminster Hospital NHS Foundation Trust · GBLondon School of Hygiene & Tropical Medicine · GBNational Institute for Health and Care Excellence · GBPublic Health England · GBRoyal Sussex County Hospital · GB

Funding

Medical Research Council MC_UU_12023/23Medical Research Council MRC_UU_12023/23
6 · The paper itself

Abstract

objectivesPre-exposure prophylaxis (PrEP) is a highly effective method of HIV prevention for men who have sex with men (MSM). However, uncertainty remains around the optimal eligibility criteria for PrEP, specifically whether there are subgroups at low risk of HIV for whom PrEP might not be warranted.

methodsPROUD was an open-label waitlist trial design that randomised MSM attending participating sexual health centres in England to receive PrEP immediately (IMM) or after a deferral period of 1 year (DEF). This analysis is based on participants who were randomised to the deferred arm, when they did not have access to PrEP. HIV incidence was compared between subgroups defined by baseline characteristics.

resultsOverall, 21 participants acquired HIV infection over 239.3 person-years (PY) follow-up, yielding an incidence rate of 8.8/100 PY (95% CI 5.4 to 13.4). Two highly significant predictors for HIV acquisition were identified. Men with a self-reported diagnosis of syphilis, rectal chlamydia (CT) or rectal gonorrhoea (GC) in the previous 12 months had an incidence of 17.2/100 PY (95% CI 9.7 to 28.5); those reporting receptive anal intercourse without a condom (ncRAI) with two or more partners in the previous 3 months had an incidence of 13.6/100 PY (95% CI 7.9 to 21.7). The incidence rate among participants lacking both of these risk factors was 1.1/100 PY (1/87.6, 95% CI 0.03 to 6.4).

conclusionsThe high HIV incidence in PROUD suggests that most participants appropriately judged their need for PrEP. Eligibility criteria for a PrEP programme can therefore be broad, as in the current guidelines. However, a recent history of syphilis or rectal CT/GC, or multiple ncRAI partners indicates a high imminent risk of HIV infection. MSM with any of these characteristics should be offered PrEP as a matter of urgency.

Indexed as

AdolescentAdultAnti-HIV AgentsEnglandHIV InfectionsHomosexuality, MaleHumansMaleMiddle AgedPre-Exposure ProphylaxisSexual BehaviorYoung AdultAnti-HIV Agentseligibility criteriaHIVMSMPrEP

Identifiers

PMID30918121
PMCPMC6824743
OpenAlexW2926797564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.